SCHEMBL8205528

SCHEMBL8205528

C[N+](C)(C)Cc1n[nH]c2c(F)cccc12

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 3/20 0.40
▸ GPR84 Q9NQS5 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ SLC6A4 P31645 6/20 0.34
▸ MPO P05164 4/20 0.34
▸ MAPK10 P53779 1/20 0.34
▸ RIPK1 Q13546 1/20 0.34
▸ FEN1 P39748 1/20 0.33
▸ TP53 P04637 1/20 0.32
▸ PARP1 P09874 1/20 0.32
▸ CHEK1 O14757 1/20 0.31
▸ FLT3 P36888 1/20 0.31
▸ PLK3 Q9H4B4 1/20 0.31
▸ CA12 O43570 1/20 0.31
▸ CA9 Q16790 1/20 0.31
▸ TRPA1 O75762 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13122355 0.81 AR (0.43) ARGPR84LMNASLC6A4MPO
SCHEMBL31411334 0.75 TAAR1 (0.44) ARGPR84SLC6A4MPO
SCHEMBL5638323 0.73 AR (0.39) ARGPR84LMNASLC6A4MPO
SCHEMBL8212290 0.73 KDM4E (0.47) MAPK10TP53FLT3TRPA1
SCHEMBL30998058 0.72 AR (0.38) ARGPR84LMNASLC6A4MPO
SCHEMBL4234184 0.72 ADORA2A (0.41) ARGPR84LMNASLC6A4MPO
SCHEMBL31411439 0.72 HTR2A (0.48) ARGPR84SLC6A4MPOPARP1
Iodide SCHEMBL1595770 0.71 KDM4E (0.46) MAPK10TP53FLT3TRPA1
SCHEMBL17515575 0.71 MAPK10 (0.36) ARGPR84LMNASLC6A4MPO
SCHEMBL14158304 0.70 TNKS (0.44) GPR84LMNAMAPK10RIPK1FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008040995-A9 INDAZOLES FOR USE AS DPP-IV INHIBITORS PEAKDALE MOLECULAR LTD (GB) 2008-12-31 — — WO disclosed
WO-2008040995-A1 INDAZOLES FOR USE AS DPP-IV INHIBITORS PEAKDALE MOLECULAR LIMITED (GB) 2008-04-10 — — WO disclosed
Send feedback